JGJan Gruber

Jan Gruber

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jan Gruber has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Predicting and finding geroprotective compounds through modulating conserved longevity–associated aging modules

    by Weihan Huai, Li-Fang Ng, Jasinda H. Lee, Qingyun Wang, Kamil Pabis, Zhuangli Yee, Shivaanisha Raventhiran, Shou-Ping Guan, Shermaine Thein, Stephen Dinesh Raj, et al.

    Currently, no generalizable tools exist for predicting the impact of interventions on aging using gene expression changes. Here, we build a model for predicting potential geroprotectors by deconstructing the aging transcriptome into coexpression modules and identifying those modulated by life span–extending interventions in Caenorhabditis elegans ( C. elegans ). Many of these modules exhibited adaptive changes during aging that are linked to longevity. Using these longevity-associated modules, we predicted and validated 10 compounds (7 previously unreported) that significantly extended life span in C. elegans . RNA sequencing analysis of two top candidates also showed targeted modulation of our longevity-associated modules. We identified conservation of several modules in mice that were also correlated with frailty. Together, our findings demonstrate that beneficial transcriptomic adaptations occur during aging and that targeting longevity-associated modules offers a framework for geroprotector discovery.

  • Open Access

    Old worms, new tricks: dynamical instability explains late-life rejuvenation in C. elegans

    by Djakim Latumalea, Adrian Molière, Peter Fedichev, Collin Y. Ewald, Jan Gruber

    How is it possible to double the lifespan of an organism already close to death? Many biological theories of aging fail to explain this phenomenon. At the Physics of Aging workshop, we presented and discussed late-life lifespan extension in Caenorhabditis elegans to illustrate how a simple stochastic dynamical systems model can account for dramatic geriatric interventions. We build on a Langevin-type instability framework in which aging is a manifestation of dynamical instability–a scenario where stochastic fluctuations amplify over time, driving the system toward a failure thresh-old at which death occurs as a first-passage event. The instability rate α (equivalently, the inverse of the mortality-rate doubling time) quantifies the speed of this divergence: a larger α means faster exponential growth of z , a steeper Gompertz slope, and a shorter lifespan. The failure threshold z max ≈α/g , where g is the strength of nonlinear feedback, marks the point beyond which the system diverges irreversibly—physiologically, the saturation of metabolic and regulatory capacity. Within this dynamical-systems framework, auxin-induced degradation of the insulin/IGF-1 receptor DAF-2 in very old animals is naturally interpreted as a late shift in stability parameters that nearly doubles remaining lifespan without resetting accumulated structural damage. This interpretation reconciles the persistence of many senescent pathologies with restored proteostasis and stress resilience, and it shows that targeting the dynamical instability of the regulatory network–rather than reversing damage—can strongly reshape survival trajectories in unstable animals. More broadly, our work exemplifies how physics-inspired low-dimensional stochastic models can capture key features of aging, and we hope it will inspire more collaborations between biologists and physicists to work on late-life interventions.

  • Open Access

    Partial Reprogramming Is Conserved from Insect to Mammal

    by Nicholas S. Tolwinski, Sheng Fong, Sujithra Shankar, Jan Gruber

    As we become older, systems throughout the body gradually decline in function. Contributing factors include the accumulation of senescent cells and the dysfunction and exhaustion of stem and progenitor cells. A promising approach to mitigate these changes and enhance cellular function in aged animals is the discovery that differentiated cells retain plasticity, enabling them to revert to pluripotent states when exposed to Yamanaka factors. This method has shown promise in models of rapid aging, and recent studies have demonstrated notable life extension in both flies and mice. These findings, along with the development of senolytics and aging clocks, could revolutionize aging research and interventions. Here, we review recent discoveries in the field and propose new directions for intervention discovery.


  • Reframing biological age as risk-equivalent age

    by Sheng Fong, Woon-Puay Koh, Jan Gruber


  • Open Access

    LinAge2: providing actionable insights and benchmarking with epigenetic clocks

    by Sheng Fong, Kirill A. Denisov, Anastasiia A. Nefedova, Brian K. Kennedy, Jan Gruber

    Biological aging is marked by a decline in resilience at the cellular and systemic levels, driving an exponential increase in mortality risk. Here, we evaluate several clinical and epigenetic clocks for their ability to predict mortality, demonstrating that clocks trained on survival and functional aging outperform those trained on chronological age. We present an enhanced clinical clock that predicts mortality more accurately and provides actionable insights for guiding personalized interventions. These findings highlight the potential of mortality-predicting clocks to inform clinical decision-making and promote strategies for healthy longevity.


  • Open Access

    LinAge2: Providing actionable insights and benchmarking with epigenetic clocks

    by Sheng Fong, Kirill A. Denisov, Brian K. Kennedy, Jan Gruber

    Biological aging is marked by a decline in resilience at the cellular and systemic levels, driving an exponential increase in mortality risk. Here, we evaluate several clinical and epigenetic clocks for their ability to predict mortality, demonstrating that clocks trained on survival and functional aging outperform those trained on chronological age. We present an enhanced clinical clock that predicts mortality more accurately and provides actionable insights for guiding personalized interventions. These findings highlight the potential of mortality-predicting clocks to inform clinical decision-making and promote strategies for healthy longevity.

  • Open Access

    Discovery of Thermodynamic Control Variables that Independently Regulate Healthspan and Maximum Lifespan

    by Kirill A. Denisov, Jan Gruber, Peter O. Fedichev

    The question, “Can aging be modified, delayed, or reversed?” has profound social and economic implications for rapidly aging societies today. Interventions, ideally, would intercept functional decline and extend healthspan by delaying late-life morbidity (known as “squaring the curve”). These have proven elusive, but examples of differential aging in the animal world abound, suggesting aging itself is a malleable process. We present a novel multi-scale theoretical framework for entropic aging, and apply it to recently published DNA methylation data from 348 evolutionarily distant mammalian species. Our analysis identified modules or correlated DNA methylation changes associated with reversible pathway activation in key biological processes. We discovered a single species-dependent scaling factor controlling the magnitude of fluctuations across biological pathways. It acts as the organism’s “effective temperature”, quantifying intrinsic biological noise within networks and is unrelated to physical body temperature. Furthermore, we find a distinct stochastic damage signature and an associated extreme value (Gumbel) distribution of activation barriers controlling site-specific damage rates of individual CpG sites. This implies that aging is driven by rare, high-energy transitions on rugged energy landscape, most likely simultaneous and hence practically irreversible failures in highly redundant systems. While the overall rate of damage accumulation and hence the maximum lifespan does not depend on the effective temperature driving the noise in leading pathways, effective temperature does influence both initial mortality rate and the mortality rate doubling time – thereby shaping the survival curve. Lowering effective temperature must, therefore, be a promising Geroscience strategy, aimed directly at squaring the curve of aging. The example shows that targeting the thermodynamic forces driving mammalian aging may provide powerful strategies for the development of truly meaningful interventions to combat aging in humans.


  • Open Access

    Towards Healthy Longevity: Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks

    by Khalishah Yusri, Sanjay Kumar, Sheng Fong, Jan Gruber, Vincenzo Sorrentino

    Aging is a complex and time-dependent decline in physiological function that affects most organisms, leading to increased risk of age-related diseases. Investigating the molecular underpinnings of aging is crucial to identify geroprotectors, precisely quantify biological age, and propose healthy longevity approaches. This review explores pathways that are currently being investigated as intervention targets and aging biomarkers spanning molecular, cellular, and systemic dimensions. Interventions that target these hallmarks may ameliorate the aging process, with some progressing to clinical trials. Biomarkers of these hallmarks are used to estimate biological aging and risk of aging-associated disease. Utilizing aging biomarkers, biological aging clocks can be constructed that predict a state of abnormal aging, age-related diseases, and increased mortality. Biological age estimation can therefore provide the basis for a fine-grained risk stratification by predicting all-cause mortality well ahead of the onset of specific diseases, thus offering a window for intervention. Yet, despite technological advancements, challenges persist due to individual variability and the dynamic nature of these biomarkers. Addressing this requires longitudinal studies for robust biomarker identification. Overall, utilizing the hallmarks of aging to discover new drug targets and develop new biomarkers opens new frontiers in medicine. Prospects involve multi-omics integration, machine learning, and personalized approaches for targeted interventions, promising a healthier aging population.


  • Open Access

    Principal component-based clinical aging clocks identify signatures of healthy aging and targets for clinical intervention

    by Sheng Fong, Kamil Pabis, Djakim Latumalea, Nomuundari Dugersuren, Maximilian Unfried, Nicholas Tolwinski, Brian Kennedy, Jan Gruber

    Clocks that measure biological age should predict all-cause mortality and give rise to actionable insights to promote healthy aging. Here we applied dimensionality reduction by principal component analysis to clinical data to generate a clinical aging clock (PCAge) identifying signatures (principal components) separating healthy and unhealthy aging trajectories. We found signatures of metabolic dysregulation, cardiac and renal dysfunction and inflammation that predict unsuccessful aging, and we demonstrate that these processes can be impacted using well-established drug interventions. Furthermore, we generated a streamlined aging clock (LinAge), based directly on PCAge, which maintains equivalent predictive power but relies on substantially fewer features. Finally, we demonstrate that our approach can be tailored to individual datasets, by re-training a custom clinical clock (CALinAge), for use in the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE) study of caloric restriction. Our analysis of CALERIE participants suggests that 2 years of mild caloric restriction significantly reduces biological age. Altogether, we demonstrate that this dimensionality reduction approach, through integrating different biological markers, can provide targets for preventative medicine and the promotion of healthy aging.


  • Open Access

    A concerted increase in readthrough and intron retention drives transposon expression during aging and senescence

    by Kamil Pabis, Diogo Barardo, Olga Sirbu, Kumar Selvarajoo, Jan Gruber, Brian K Kennedy

    Aging and senescence are characterized by pervasive transcriptional dysfunction, including increased expression of transposons and introns. Our aim was to elucidate mechanisms behind this increased expression. Most transposons are found within genes and introns, with a large minority being close to genes. This raises the possibility that transcriptional readthrough and intron retention are responsible for age-related changes in transposon expression rather than expression of autonomous transposons. To test this, we compiled public RNA-seq datasets from aged human fibroblasts, replicative and drug-induced senescence in human cells, and RNA-seq from aging mice and senescent mouse cells. Indeed, our reanalysis revealed a correlation between transposons expression, intron retention, and transcriptional readthrough across samples and within samples. Both intron retention and readthrough increased with aging or cellular senescence and these transcriptional defects were more pronounced in human samples as compared to those of mice. In support of a causal connection between readthrough and transposon expression, analysis of models showing induced transcriptional readthrough confirmed that they also show elevated transposon expression. Taken together, our data suggest that elevated transposon reads during aging seen in various RNA-seq dataset are concomitant with multiple transcriptional defects. Intron retention and transcriptional readthrough are the most likely explanation for the expression of transposable elements that lack a functional promoter.